Clinical Trials Logo

GBS clinical trials

View clinical trials related to GBS.

Filter by:
  • None
  • Page 1

NCT ID: NCT04871035 Recruiting - GBS Clinical Trials

Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)

IPET-GBS
Start date: April 28, 2021
Phase:
Study type: Observational

This is an observations study evaluating safety and efficacy of immunoadsorption compared to plasma exchange in Guillain-Barré Syndrome.

NCT ID: NCT04434391 Completed - GBS Clinical Trials

QF-PCR In GBS Diagnosis During Pregnancy

QFPCRIGDDP
Start date: August 2013
Phase:
Study type: Observational

Estimate the sensitivity and specificity of Quantitative Fluorescence Polymerase Chain Reaction (QF-PCR) in diagnosing Group B Strep (GBS) rectovaginal colonization during pregnancy, and follow the outcome of the mothers and infants. According to the outcome of this study,the investigator wish to determine that wether QF-PCR is an appropriate screening method for GBS in primary hospitals in China.

NCT ID: NCT04116645 Withdrawn - Clinical trials for Group B Streptococcal Infection

Time Frame for GBS Screening

Start date: November 1, 2020
Phase:
Study type: Observational

All pregnant women prenatally being followed up or admitted at Rambam HealthCare Campus, Haifa, Israel are potential participants in the study. If a patient is agreeable, the nurse/physician/research coordinator will obtain informed consent. Once informed consent is obtained, the patient can be swabbed for GBS. The swabs will be obtained at the routine follow-up at the clinic at 30, 32 and 35 weeks' gestation. If a patient is found to have a positive GBS culture at 35 weeks, she will receive antibiotic treatment during labour according to the protocol. GBS swabs taken at delivery will be compared to previous swabs taken at an earlier gestational age in order to evaluate sensitivity, specificity, positive and negative predictive values of GBS swabs at each week of gestation and to determine the value of our primary hypothesis.

NCT ID: NCT03936816 Completed - GBS Clinical Trials

The Implementation of Real-time PCR - Intrapartum GBS (Group B Streptococcus) Colonization to Reduce Antibiotic Prophylaxis

Start date: June 1, 2019
Phase:
Study type: Observational

The implementation of real-time PCR for detection of intrapartum GBS (group B Streptococcus) colonization as a way to reduce antibiotic prophylaxis usage.

NCT ID: NCT03064672 Not yet recruiting - GBS Clinical Trials

Transcervical Balloon Catheters in GBS Carriers, Is It Safe? A Randomized Controlled Trial

Start date: December 2020
Phase: N/A
Study type: Interventional

This prospective cohort study aims to determine whether maternal and neonatal outcomes are affected by GBS carrier status in women undergoing transcervical balloon catheter insertion.

NCT ID: NCT03008421 Completed - Clinical trials for Pregnancy Complications

Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

In the present study, the investigators aim to evaluate the potential of oral probiotics, containing Lactobacillus strains, to eradicate and reduce the vaginal colonization with group B Streptococcus (GBS) during pregnancy. This could help to prevent neonatal morbidity and mortality by reducing the risk for neonatal sepsis, pneumonia, and meningitis, known as early-onset or late-onset GBS infection.

NCT ID: NCT02883270 Completed - GBS Clinical Trials

Effects of Robotic-assisted Gait Training In Non-Ambulatory Patients After Guillain-Barré Syndrome

Start date: August 2014
Phase: N/A
Study type: Interventional

This study investigates the effects of Robotic-assisted gait training in non-ambulatory patients after Guillain-Barré syndrome.The participants are randomly divided into two groups.Patients of the treatment group receive robotic-assisted gait training,while the contorls receive conventional rehabilitation.

NCT ID: NCT02497430 Completed - Pregnancy Clinical Trials

Clinical Evaluation of the ARIES Group B Streptococcus (GBS) Assay

Start date: March 2016
Phase: N/A
Study type: Observational

The ARIES GBS Assay is a real-time PCR based qualitative test designed to detect Group B Streptococcus (GBS) nucleic acid from Lim Broth enriched vaginal-rectal specimen swabs obtained from pregnant women between 35 - 37 weeks gestation.

NCT ID: NCT01833780 Not yet recruiting - GBS Clinical Trials

Effectiveness of Intrapartum Group B Streptococcus (GBS) Polimerase Chain Reaction Reaction (PCR) Screening

Start date: May 2013
Phase: N/A
Study type: Observational [Patient Registry]

Study hypothesis: Intrapartum polimeraze chain reaction (PCR)of group B streptoccocus (GBS) test is more accurate than Culture of GBS at 35-37 weeks gestation for GBS carriage. The investigators will compare GBS culture and PCR results taken at 35-37 weeks gestation to intrapartum PCR GBS and GBS cultures status. The larger perspective of this trial is to check the possibility of replacing the GBS culture screening program at 35-37 weeks gestation with a more accurate examination (PCR), avoiding the changing GBS carriage status from the time of culture at 35-37 weeks to delivery.